II
Instylla, Inc.
SEC filingBiotechnology · Bedford, MA
Amount raised$34.8Msold at filing
Total offering$35M$250K still open
Investors in the raise29count reported to the SEC
FiledJul 28, 2026first sale Jul 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sean ChengDirector
Farhad KhosraviDirector
Tasneem DohadwalaDirector
Steven CagnettaExecutive Officer
Darshana ZaveriDirector
Sean BoyleDirector
Amarpreet SawhneyExecutive Officer
Henry ChenDirector
Daniel DavisDirector
Executive officers, directors and promoters as listed on the Form D.